Class I:Superpotentsteroids.</p></li><li><p>ClassVII:Leastpotentsteroids.</p></li></ul></li></ul><p>ATOPICDERMATITISPEARLS</p><ul><li><p><strong>CorticosteroidsUse:</strong></p><ul><li><p>Systemicglucocorticoidsshouldbeavoidedexceptforrareinstancesofsevere,intractablediseaseinadults.</p></li></ul></li><li><p><strong>MoistureRetention:</strong></p><ul><li><p>Applyemollientsimmediatelyafterbathingtolockinmoisture.</p></li></ul></li><li><p><strong>NaturalCourse:</strong></p><ul><li><p>Spontaneousremissionoccursinover40\%ofchildhoodcases.</p></li></ul></li></ul><p>CONTACTDERMATITIS</p><ul><li><p><strong>Definition:</strong></p><ul><li><p>Erythemaandedemawithaccompanyingpruritus,vesicles,bullae,weeping,orcrusting.</p></li></ul></li><li><p><strong>IrritantContactDermatitis:</strong></p><ul><li><p>Occurssolelyintheareaofdirectcontactwiththeirritant.</p></li></ul></li><li><p><strong>AllergicContactDermatitis:</strong></p><ul><li><p>Extendsbeyondtheareaofdirectcontactwiththeallergen.</p></li></ul></li></ul><p>IRRITANTCONTACTDERMATITIS</p><ul><li><p><strong>Characteristics:</strong></p><ul><li><p>Sharplydemarcatederythema,edema,possiblevesicles/bullae.</p></li><li><p>Mostcommonlyfoundonhands.</p></li><li><p>Candevelopwithin24hourspost−exposure.</p></li></ul></li><li><p><strong>CommonIrritants:</strong></p><ul><li><p>Soaps,detergents,organicsolvents.</p></li></ul></li></ul><p>ALLERGICCONTACTDERMATITIS</p><ul><li><p><strong>Symptoms:</strong></p><ul><li><p>Intensepruritus,erythema,tinypapules/vesicles,weepyorcrustedlesions;seldompainful.</p></li><li><p>Involvementbeyondcontactarea,maypresentwithedematousandwarmlesions.</p></li><li><p>Symptomscantake48hoursormoretodeveloppost−exposure.</p></li></ul></li><li><p><strong>CommonAllergens:</strong></p><ul><li><p>Poisonivy/oak,topicalantibiotics,hairdye,jewelry,rubberproducts,essentialoils,adhesives.</p></li></ul></li></ul><p>CONTACTDERMATITISTREATMENT</p><ul><li><p><strong>ManagementApproach:</strong></p><ul><li><p>Identifyandeliminatethecausativeagent.</p></li><li><p>Otherwise,applywetdressingsmultipletimesaday.</p></li><li><p>Utilizetopicalglucocorticoidsonaffectedareas.</p></li><li><p>Inseverecases,oralsteroidslikePrednisoneat60\ mgdailywithtaperingover2-3weeks.</p></li></ul></li><li><p><strong>Prognosis:</strong></p><ul><li><p>Generallygood;resolutionmaytake2-3weeksdependingoncausativefactors.</p></li></ul></li></ul><p>PATCHTESTING</p><ul><li><p><strong>Purpose:</strong></p><ul><li><p>Documentandvalidatediagnosisofallergiccontactsensitizationandidentifycausativeagents.</p></li></ul></li><li><p><strong>Procedure:</strong></p><ul><li><p>Testsubstancesareappliedtoskinwithinshallowcups(Finnchambers),tapedandkeptfor24-48hours.</p></li><li><p>Contacthypersensitivityisindicatedbypapularvesicularreactionobservedwithin48-72hourswhenthetestisassessed.</p></li></ul></li></ul><p>LICHENPLANUS</p><ul><li><p><strong>Definition:</strong></p><ul><li><p>ApruriticinflammatorydiseasecharacterizedbyfourP’s:Pruritic,Purple,Polygonal,Papules/Plaques.</p></li></ul></li><li><p><strong>Demographics:</strong></p><ul><li><p>Mostcommonlyfoundinmiddle−agedadults.</p></li></ul></li><li><p><strong>CardinalFindings:</strong></p><ul><li><p>Classiclichenplanuslesionsonskinandmucosa;histopathologicalidentificationrevealsband−likeinfiltrationoflymphocytesintheupperdermis.</p></li></ul></li><li><p><strong>PossibleLinktoHepatitisC:</strong></p><ul><li><p>Currentstudiessuggestacorrelation.</p></li></ul></li><li><p><strong>ClinicalPresentation:</strong></p><ul><li><p>Pruritic,violaceous,flat−toppedpapulesexhibitfinewhitestreaks(Wickhamstriae).</p></li><li><p>Oralmucosalinvolvement:Lacy(Wickhamstriae)orerosivelesions.</p></li><li><p><strong>KoebnerPhenomenon:</strong>Appearanceoflesionsinareasoftrauma.</p></li></ul></li><li><p><strong>RiskofCancer:</strong></p><ul><li><p>Patientswitherosiveoral/genitallichenplanushaveuptoa5\%riskofdevelopingsquamouscellcarcinoma(SCC).</p></li></ul></li><li><p><strong>Treatment:</strong></p><ul><li><p>Oftenresolvesspontaneouslyin1-2years.High−potencytopicalsteroidsarefirst−line.</p></li></ul></li></ul><p>LICHENSIMPLEXCHRONICUS</p><ul><li><p>Arisesfromchronichabitualrubbingandscratching.</p></li><li><p><strong>Presentation:</strong>Solidplaqueswithlichenification(thickenedskinwithaccentuatedmarkings).</p></li><li><p><strong>Management:</strong>Behavioralchangeandhigh−potencytopicalsteroids,oftenwithocclusion.</p></li></ul><p>PITYRIASISROSEA</p><ul><li><p><strong>Overview:</strong>MildacuteinflammatorydiseaselikelycausedbyHHV−6orHHV−7.</p></li><li><p><strong>ClinicalFindings:</strong>Startswitha"heraldpatch"(initiallargerplaque)followedbyageneralizederuptionofovalsalmon−coloredplaquesina"Christmastree"distribution.</p></li><li><p><strong>Treatment:</strong>Self−limitingover6-12weeks.Symptomaticreliefwithtopicalsteroids/antihistamines.</p></li></ul><p>PSORIASIS</p><ul><li><p><strong>Definition:</strong>Chronicinflammatorydisorderwithgeneticcomponents.Triggersincludestress,trauma(Koebner),andinfections.</p></li><li><p><strong>Types:</strong>Plaque,Guttate(post−strep),Inverse,Palmoplantar,Pustular.</p></li><li><p><strong>ClinicalPresentation:</strong>Sharplydelineatedredplaqueswithsilver−whitescaling.<strong>Auspitzsign</strong>(pinpointbleedingwhenscaleisremoved).</p></li><li><p><strong>Treatment:</strong></p><ul><li><p>Localized:TopicalsteroidsandVitaminDanalogs.</p></li><li><p>Severe:UVphototherapy,Methotrexate,TNFinhibitors,orIL−17/IL−23inhibitors.</p></li></ul></li></ul><p>SEBORRHEICDERMATITIS</p><ul><li><p><strong>Definition:</strong>Chronicconditioninareaswithsebaceousglandactivity.Associatedwith<em>Malasseziafurfur</em>.</p></li><li><p><strong>Presentation:</strong>Orangish−yellowishgreasyscales.Knownas"cradlecap"ininfants.</p></li><li><p><strong>Treatment:</strong>Ketoconazolecream/shampoo,seleniumsulfide,orlow−potencysteroids.</p></li></ul><h6id="a4e4dcd6−ea36−4778−b232−03333889528c"data−toc−id="a4e4dcd6−ea36−4778−b232−03333889528c"collapsed="false"seolevelmigrated="true">VASCULARABNORMALITIES</h6><p>TELANGIECTASIA</p><ul><li><p><strong>Definition:</strong>Dilatedcapillariesneartheskinsurfacethatareblanchable.</p></li><li><p><strong>Treatment:</strong>Laserorelectrosurgeryifcosmeticcorrectionisdesired.</p></li></ul><p>CHERRYANGIOMA</p><ul><li><p><strong>Characteristics:</strong>Benign,asymptomaticbrightredpapulesappearingafterage30.</p></li></ul><p>INFANTILEHEMANGIOMA</p><ul><li><p>Commonbenigntumorofinfancy.Oftenundergoesspontaneousinvolutionbyage10.Propranololmaybeusedforobstructinglesions.</p></li></ul><p>PORTWINESTAIN(NEVUSFLAMMEUS)</p><ul><li><p><strong>Definition:</strong>Apermanentcapillarymalformationpresentatbirth.</p></li><li><p><strong>ClinicalPresentation:</strong>Flat,pinktodarkredpatchesthatdonotregress.Oftenfollowdistributionofthetrigeminalnerve.</p></li><li><p><strong>Associations:</strong>MaybelinkedtoSturge−Webersyndrome.</p></li></ul><p>STASISDERMATITIS</p><ul><li><p><strong>Pathophysiology:</strong>Chronicvenousinsufficiency.</p></li><li><p><strong>Presentation:</strong>Erythema,scaling,andhyperpigmentation(hemosiderinstaining)onthelowerlegs/ankles.</p></li></ul><p>PURPURA</p><ul><li><p>Non−blanchablespotsfrombloodextravasation.</p></li><li><p><strong>Petechiae:</strong>< 3\ mm.<strong>Ecchymoses:</strong>> 1\ cm$$.